3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD. ... in HFrEF on GDMT ... outcomes in HFrEF ... on GDMT, with or ... SGLT2 #inhibitors #EBM
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... diagnosis #management #cardiology